Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01236300 · ClinicalTrials.gov registry record · NA
In Vivo nCLE Study in the Pancreas With Endosonography of Cystic Tumors
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT01236300: Completed NA study, sponsored by University of Chicago.
NCT01236300 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01236300, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
Assess the safety and efficacy of the Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) system in differentiating benign from malignant and premalignant cysts (e.g. mucinous from non-mucinous cysts)
Primary Outcome
Using the descriptive criteria of the nCLE images of mucinous vs. non mucinous cysts determined in stage 1, we assessed diagnostic parameters of needle-based confocal laser endomicroscopy of for the detection of pancreatic cystic neoplasia in stage 2. For patients who underwent surgery, a gold standard diagnosis was obtained by histopathological diagnosis of the surgical specimen. The local pathologist reviewed the histology slides and selected key areas for high-resolution digital photography.
Interventions
- DEVICE Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-05 |
| Phase | NA |
What the finished NCT01236300 record still lists
NCT01236300 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) system is the first listed.
NCT01236300 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01236300 about?
NCT01236300 is a clinical study titled "In Vivo nCLE Study in the Pancreas With Endosonography of Cystic Tumors". Assess the safety and efficacy of the Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) system in differentiating benign from malignant and premalignant cysts (e.g. mucinous from non-mucinous cysts)
What is the current status of trial NCT01236300?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2010-07. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01236300?
The interventions under investigation include: Cellvizio needle-based Confocal Laser Endomicroscopy (nCLE) system (DEVICE).
Who is sponsoring clinical trial NCT01236300?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01236300's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia